ClinicalTrials.Veeva

Menu

A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis

H

Hospital Authority, Hong Kong

Status and phase

Completed
Phase 3

Conditions

Glomerulonephritis, Membranous
Lupus Nephritis

Treatments

Drug: prednisolone and mycophenolate mofetil
Drug: prednisolone and tacrolimus

Study type

Interventional

Funder types

Other

Identifiers

NCT00404794
HARECCTR0500003
UW05-205 T/868

Details and patient eligibility

About

This is a prospective randomized open-label pilot study to compare mycophenolate mofetil in combination with corticosteroid treatment and tacrolimus in combination with corticosteroid treatment in membranous lupus nephritis. The change in urine protein excretion will be the primary outcome studied. The study duration will be 24 months for each patient.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • abnormal urine protein excretion and biopsy-proven membranous lupus nephritis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems